Hemin has a profound effect on erythroid cell maturation and promotes fetal hemoglobin synthesis in vitro. In β-thalassemia, increasing fetal hemoglobin levels can ameliorate the anemia. We administered heme arginate, a novel stable form of hemin, to 4 patients with thalassemia intermedia and studied the in vitro versus in vivo effects. In erythroid cultures, there was a marked rise in total hemoglobin and hemoglobin F. In vivo, 3 of 4 patients had a rise in hemoglobin levels (from 0.4 to 1.1 g%), which was statistically significant in 1 patient. There were no serious adverse effects. Heme arginate may be useful in the treatment of thalassemia intermedia.

Keywords:
Hemoglobin, fetal, Hemoglobinopathies, Thalassemia intermedia
1.
Porter P, Meints R, Mesner K: Enhancement of erythroid colony growth in culture by hemin. Exp Hematol 1979;7:11–16.
2.
Rutherford T, Clegg J, Weatherall D: K562 human erythroleukemia cells. Nature 1979;280:164–165.
3.
Alter B, Schoenfield J, He L, Weinberg R: Effects of hemin on erythropoiesis. Adv Exp Med Biol 1989;271:95–102.
4.
Fibach E, Kollia P, Schechter A, Noguchi C, Rodgers GP: Hemin-induced acceleration of hemoglobin production in immature cultured erythroid cells: Preferential enhancement of fetal hemoglobin. Blood 1995;85:2967–2974.
5.
Tenhunen R, Tokola O, Linden I: Haem arginate: A new stable haem compound. J Pharm Pharmacol 1987;39:780–786.
6.
Fibach E, Manor D, Oppenheim A, Rachmilewitz E: Proliferation and maturation of human erythroid progenitors in liquid culture. Blood 1989;73:100–103.
7.
Epstein N, Epstein M, Boulet A, Fibach E, Rodgers G: Antibody based methods for quantitation of hemoglobins: Application to patients with sickle cell anemia treated with hydroxyurea. Eur J Haematol 1996;57:17–24.
8.
Timonen T, Kauma H: Therapeutic effect of heme arginate in myelodysplastic syndromes. Eur J Haematol 1992;49:234–238.
9.
Chalevelakis G, Karaoulis S, Yalouris A, Economopoulos T, Tountas N, Raptis S: Globin chain synthesis in myelodysplastic syndromes. J Clin Pathol 1991;44:134–138.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.